COMMUNIQUÉS West-GlobeNewswire

C-RAD publishes outcome of Employee Warrant Program 2018/2021

19/06/2018 - 08:30

C-RAD has launched a warrant program for its employees. All warrants that were offered to current employees were subscribed for. The Annual Shareholder Meeting decided in May 2018 to issue 100,000 warrants for the [...]

Constitutive meeting of Biohit Oyj’s Board of Directors

19/06/2018 - 08:30

Biohit Oyj Other information disclosed according to the rules of the Exchange June 19, 2018 at 9:30 am local time (EEST) Biohit Oyj’s Board of Directors has in its meeting yesterday elected Mr Osmo Suovaniemi as the [...]

Shire plc: Rule 2.9 Announcement

19/06/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 19 June 2018 Shire [...]

Medibio Receives TGA Approval

19/06/2018 - 08:00

SYDNEY, Australia and MINNEAPOLIS, June 19, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company )(ASX:MEB)(OTCQB:MDBIF), a mental health technology company, announced today it has received confirmation that [...]

Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer

19/06/2018 - 07:45

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer Paris - June 19, 2018 - Sanofi has appointed Jean-Baptiste [...]

Sanofi nomme Jean-Baptiste Chasseloup de Chatillon au poste de Vice-Président Exécutif, Directeur financier

19/06/2018 - 07:45

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Sanofi nomme Jean-Baptiste Chasseloup de Chatillon au poste de Vice-Président Exécutif, Directeur financier Paris - Le 19 juin 2018 - Sanofi vient de [...]

Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity and development of innovative technologies

19/06/2018 - 07:18

Total investment can reach EUR 7.25 million upon exercise of share subscription warrants Amsterdam, The Netherlands - 19 June 2018 Transaction highlights Potential financing of up to EUR 5 million through private [...]

Sanofi : Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure

19/06/2018 - 07:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure Paris, France and Ghent, Belgium - June 19, 2018 - Sanofi ( [...]

Sanofi : Sanofi finalise l'acquisition d'Ablynx à la suite de l'expiration de la procédure d'offre de reprise

19/06/2018 - 07:01

Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi finalise l'acquisition d'Ablynx à la suite de l'expiration de la procédure d'offre de reprise Paris, France et Gand, Belgique - Le 19 juin 2018 - [...]

SANOFI COMPLETES ITS ACQUITISION OF ABLYNX FOLLOWING THE EXPIRATION OF THE SQUEEZE-OUT PROCEDURE

19/06/2018 - 07:01

PARIS, France and GHENT, Belgium - June 19, 2018 - Sanofi (Euronext: SAN; NYSE: SNY) and Ablynx announced today that Sanofi has now acquired all outstanding shares (including shares represented by American Depositary [...]

CH Biotech Announces Grand Opening of Global R&D Innovation Center and Corporate Headquarters

19/06/2018 - 04:00

New Facility Is Taiwan's First International R&D Center Focused on Integrating Plant Health Systems NANTOU CITY, Taiwan, June 18, 2018 (GLOBE NEWSWIRE) -- CH Biotech R&D Co., Ltd. ("CH Biotech"), a leader in [...]

REVA Extends Technological Lead in Bioresorbable Scaffolds With CE Mark Approval of the Full Fantom® Encore Product Line

19/06/2018 - 01:47

SAN DIEGO, June 18, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced it has received CE Mark [...]

BioStem Technologies Inc. Announces Issuance of Drug Enforcement Administration Registration for Qualified Pharma Ingredients

18/06/2018 - 23:30

Pompano Beach, FL, June 18, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration [...]

Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering

18/06/2018 - 23:19

BOSTON, June 18, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]

Sol-Gel Technologies Initiates Pivotal Phase III Clinical Program for Papulopustular Rosacea

18/06/2018 - 22:33

First subject dosed in pivotal Phase III program evaluating Epsolay ® in subjects with papulopustular rosacea Two Phase III trials expected to enroll a total of 700 subjects Top-line data expected to be reported in 2019 [...]

ObsEva Announces Launch of Proposed Follow-on Public Offering

18/06/2018 - 22:32

Geneva, Switzerland and Boston, MA - June 18, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]

Olainfarm Sales In The First Five Months Increase by 2%

18/06/2018 - 22:31

Olaine, June 18, 2018 Olainfarm Sales In The First Five Months Increase by 2% Consolidated Results May and 5 months of 2018 Preliminary consolidated Olainfarm Group sales in May 2018 were 8,67 million euros, which [...]

Biogen Foundation Selects Grantees to Receive $10 Million Investment for STEM Education

18/06/2018 - 22:30

CAMBRIDGE, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- The Biogen Foundation today announced the six nonprofits that will share a previously-announced four-year, $10 million grant to drive the development of local STEM ( [...]

Bradmer Pharmaceuticals, Galaxy Digital and First Coin Announce Update

18/06/2018 - 22:30

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. TORONTO, June 18, 2018 (GLOBE NEWSWIRE) -- Bradmer Pharmaceuticals Inc. (“Bradmer” or the “Company”) (TSX VENTURE:BMR.H), Galaxy [...]